H-1B filings

Does Rising Pharma Holdings Inc. sponsor H-1B?

Yes, according to public filings. Rising Pharma Holdings Inc. filed 56 H-1B labor condition applications in fiscal years 2024-2026, including 11 in fiscal year 2026.

USCIS approved 37 H-1B petitions for this employer in fiscal years 2024-2026.

This page uses public government filings. A filing does not guarantee that the employer will sponsor you. This information is not legal advice.

Status on October 22, 2026: USCIS does not collect the $100,000 payment on new H-1B petitions for workers outside the U.S. while court orders stand. Appeals are pending, so this can change. USCIS H-1B FAQ

Labor condition applications by fiscal year

Fiscal yearFiledCertifiedWorkers
2026111010
2025212121
2024242424

An employer files a labor condition application with the Department of Labor before it files an H-1B petition. A certified application is not an approved visa. The U.S. fiscal year runs from October 1 to September 30.

USCIS decisions on H-1B petitions by fiscal year

Fiscal yearNew: approvedNew: deniedContinuing: approvedContinuing: denied
20264141
20254090
202450111

New petitions are for first H-1B employment. Continuing petitions are for extensions and for workers who change employers.

Typical roles and wage ranges

Job titleApplicationsWage range per yearMedian
Director - Regulatory Affairs3$190,443 - $219,010$190,443
QA Validation Specialist3$100,000 - $125,000$100,000
Chemist3$55,000 - $65,000$65,000
Chemist II3$65,000 - $72,000$65,000
Regulatory Affairs Manager2$96,545 - $142,744$142,744
Sr. VP Finance2$259,907 - $259,907$259,907
Associate Director Quality Control2$145,600 - $145,600$145,600
Junior Business Analyst2$61,797 - $68,869$68,869
Associate Director Of Quality Assurance2$133,200 - $178,848$178,848
IT Associate2$70,000 - $70,000$70,000

Wages are the rates the employer stated in its applications. Actual pay can differ.

Top locations

LocationApplications
Decatur, IL33
East Brunswick, NJ23

Sources

Data release 2026q3, built on October 23, 2026.